OOIR: Observatory of International Research

Papers

(The H4-Index of Lancet Child & Adolescent Health is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Eliminating hepatitis B: the ball is in our court	903
Child poverty in 2023: inequity in times of crises	329
Paediatric group A streptococcal disease in England: a primary care perspective	216
Correction to Lancet Child Adolesc Health 2024; 8: 482–90	203
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial	188
Primaquine for children, once and for all	177
The health and wellbeing case for children's suffrage	175
Preventing reproductive coercion in adolescence	133
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines	133
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomis	132
Gamblification: risks of digital gambling games to adolescents	131
The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis	125
Which children in the USA have access to heroic salvage therapy?	116
Effect of the COVID-19 pandemic on adolescent mental health and substance use up to March, 2022, in Iceland: a repeated, cross-sectional, population-based study	108
Current treatment outcomes of congenital heart disease and future perspectives	101
Tackling post-discharge mortality in children living in LMICs to reduce child deaths	99
Tackling childhood cancer in sub-Saharan Africa	97
Obesity-related asthma in children and adolescents	94
Just getting bi?	90
Self-asphyxial behaviour in adolescents	89
Social determinants, inequality, and autism	87
New fellows of the UK Academy of Medical Sciences	83
Noma: a neglected oro-facial childhood disease	81
Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands	76
Trajectories of airflow limitation from childhood to early adulthood: an analysis of six population-based birth cohorts	75

Correction to Lancet Child Adolesc Health 2022; 6: 150–57	75
Correction to Lancet Child Adolesc Health 2023; 7: 684–85	72
European clinical trials in paediatric radiation oncology	71
Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry	67
Medically cleared and waiting for healing to begin	62
Adolescents and the International Conference on Population and Development at 30	61
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study	59
Longitudinal association between dysmenorrhoea in adolescence and chronic pain in adulthood: a UK population-based study	58
A call to action: children's hospitals, child health, and the climate crisis	58
Adolescent girls at the intersection of poverty, migration, and gender	55
Growth of children who are HIV-exposed but uninfected: a systematic review and meta-analysis	55
Trust, but verify: a new potential association between food allergy and asthma in children	54
The importance of sleep for adolescents' long-term development	53
Coping with and challenging the impacts of COVID-19	53
Digital media and mental health: understanding the evidence	49
“As we grieved, we grew”	48
Thank you to The Lancet Child & Adolescent Health's statistical and peer reviewers in 2023	48
Correction Lancet Child Adolesc Health 2023; 7: 588–98	48
When vaccine adverse event reporting generates hope, not fear	47
The healing powers of music	46
Pathological demand avoidance: further research is required – Authors' reply	46
Ethical and legal considerations in the care of children and young people with high consequence infectious diseases (HCIDs): an approach to decision making	46